Introduction: The itch-scratch cycle
Ever noticed how scratching an itch sometimes makes things worse? That frustrating cycle of feeling itchy and then scratching to find relief often backfires, especially for those with chronic skin conditions. Scratching doesn’t just soothe—it can actually trigger new rashes or patches on the skin, making symptoms flare up or spread.1, 3
A visual representation showing how an itch leads to scratching, which temporarily relieves discomfort but can damage the skin and intensify the itch, perpetuating a continuous cycle.
This phenomenon is part of what’s known as the Koebner phenomenon, where skin trauma like scratching leads to the development of new lesions in areas that were previously clear.1, 2, 12 For many people with diseases such as psoriasis or eczema, the itch-scratch cycle can become a self-perpetuating problem: itching prompts scratching, scratching causes skin injury, and this injury can provoke new skin lesions to emerge, worsening the condition.3, 5
Understanding this cycle is key because it highlights why managing itch is not just about comfort, but also about preventing further skin damage and disease progression. Awareness of how scratching impacts the skin and contributes to the spread of lesions offers important insight for both patients and healthcare providers.1, 4
Recognising how the Koebner phenomenon links scratching and new skin lesions helps us better understand why controlling itch is so important, so let’s take a closer look at what exactly this phenomenon involves.
What is the koebner phenomenon?
The Koebner phenomenon is a curious skin reaction in which new lesions or patches appear on previously unaffected skin after it’s been scratched, rubbed, or injured. It’s not a separate disease but rather a pattern seen in certain skin conditions where trauma seems to invite the disease to new areas of the body.1, 2
This response is well recognised in chronic inflammatory skin conditions such as psoriasis, vitiligo, and eczema.1, 12 For instance, a person with psoriasis might find that even something as minor as a scratch, sunburn, or insect bite can result in the formation of new psoriatic plaques precisely along those lines of injury. Similarly, in vitiligo, depigmented patches can develop in areas of friction or trauma, such as elbows, knees, or knuckles.1, 13
Researchers believe this reaction may be linked to an exaggerated immune response and the way skin cells communicate following injury. In susceptible individuals, skin trauma may activate immune pathways that mistakenly trigger disease mechanisms already present in the body.2, 3
Understanding this phenomenon is especially important for people managing these conditions, as even small, everyday irritations like scratching an itch can unintentionally make the condition spread.
Why does itching (Pruritus) matter?
Itching (clinically termed pruritus) describes an unpleasant sensory experience that triggers scratching behaviour. Whilst transient itching is normal, persistent or severe pruritus creates significant challenges for individuals with chronic dermatological conditions.1, 3 When itching becomes chronic, it frequently initiates repetitive scratching cycles that offer temporary relief whilst paradoxically aggravating the underlying pathology over time.5
This mechanical trauma (repeated scratching cycles) compromises the skin’s barrier function, creating micro-tears that promote inflammation and facilitate pathogen or irritant entry. In patients predisposed to the Koebner phenomenon, such recurrent damage can induce new lesions or amplify existing ones.2, 4 Consequently, pruritus and scratching establish a self-perpetuating cycle that exacerbates cutaneous disorders and delays tissue repair.3, 6
Recognising pruritus’ clinical significance is essential for effective dermatological management, as disrupting this cycle prevents further skin deterioration and alleviates patient discomfort.
Scratching and the skin: What happens underneath?
The skin serves as a protective shield, safeguarding internal tissues from environmental damage. When you scratch, it’s like creating tiny cracks in that wall. These breaks allow irritants, allergens, and bacteria to sneak in, triggering the body’s defence system to react with inflammation.2,4 This inflammation can cause redness, swelling, and discomfort, making the skin more sensitive and prone to further damage.
In people with certain skin conditions, such as psoriasis or eczema, this cycle of damage and inflammation can lead to the development of new skin lesions or patches where the skin was previously unaffected.1, 3 This process is closely linked to the Koebner phenomenon, where injury or irritation from scratching prompts the appearance of new rashes or plaques.12 So, although scratching might offer short-term relief, it actually worsens skin problems in the long run by setting off these damaging reactions beneath the surface.
Repeated scratching damages the skin’s protective surface, leading to inflammation and the potential appearance of new rashes — especially in conditions like psoriasis, where the Koebner phenomenon can be triggered.
Real-life impact
Scratching frequently initiates a self-perpetuating cycle that intensifies both the visibility and discomfort of skin conditions. Each scratch can cause new rashes or worsen existing ones, leading to increased redness, swelling, and irritation1,3 This visible damage often causes discomfort that goes beyond the physical — it can lead to emotional distress, including feelings of embarrassment, frustration, or anxiety.
For many people living with chronic skin conditions, the relentless itch and the urge to scratch disrupt sleep, leaving them tired and less able to cope with daily life.5, 8 Poor sleep can worsen their overall well-being, making it harder to manage their symptoms. In addition, the appearance of visible skin lesions can affect self-confidence and social interactions, sometimes leading to isolation or lowered self-esteem.12 The impact of scratching is therefore not just skin deep; it touches both body and mind.
What can be done to break the cycle?
Controlling chronic itch is essential to halt progressive skin deterioration.1,3 Simple measures like regular moisturiser application and cool compresses can soothe irritation and diminish scratching urges.1,3 Over-the-counter antihistamines may alleviate itching, particularly when allergies contribute to symptoms.5
Cases requiring professional intervention should involve dermatological consultation. Specialists deliver personalised treatment regimens targeting underlying conditions while optimising symptom control.12,13 Complementing medical care, practical habit-modification strategies prove valuable: maintaining short nails minimises trauma during inadvertent scratching, while fidget tools provide alternative sensory engagement to resist compulsion.3, 8 For refractory pruritus unresponsive to conventional therapy, neurokinin-1 receptor antagonists like aprepitant offer a promising alternative.9
Disrupting the itch-scratch cycle typically necessitates integrated skincare, therapeutic management, and behavioural adaptation. Effective management strategies significantly improve both skin integrity and patient wellbeing.12, 13
Frequently asked questions (FAQ)
How would you define the koebner phenomenon?
This reaction describes how physical trauma to previously normal skin can generate new pathological lesions. For instance:
- Psoriasis: Minor scratches or clothing friction may initiate new plaques1
- Vitiligo: Skin injuries often produce depigmented streaks tracing damage lines2
- Common triggers encompass abrasions, thermal burns, and tattooing12
Can scratching deteriorate existing dermatoses?
Significantly. Physical injury exacerbates inflammatory processes and initiates new lesion formation through Koebner mechanisms.3,5 Psoriasis exemplifies this: scratching induces cytokine cascades that establish plaques at injury sites.3 Studies verify recurrent damage provokes isomorphic reactions in chronic skin diseases,5 driving symptom chronicity and territorial expansion.15
What drives the overwhelming compulsion to scratch?
The urge to scratch is mediated by complex interactions between nerve fibres and skin cells, often referred to as neurocutaneous pathways. These neural–skin networks transmit itch signals through key mediators:
- Histamine and substance P (a neuropeptide that transmits itch signals) activate spinal neurokinin receptor 1 (NKR1or NK1), propagating itch6, 11
- Chronic dysfunction heightens cutaneous hypersensitivity, “increased skin sensitivity to stimuli” 3, 8
- Psoriasis/eczema creates feedback loops11, 13
- Xerosis, irritants and stress potentiate neural sensitisation14, 15
What practical methods reduce scratching damage?
Mitigation strategies:
- Chilled cloths suppress local itch signalling8
- Hydrating emollients with ceramides restore barrier function8
- Nail maintenance prevents deep excoriation during sleep
- Tactile substitutes (e.g., stress balls) divert compulsive urges
- Refractory cases warrant specialist interventions like neurokinin receptor 1 (NKR1 or NK1) antagonists7, 10
Does Koebnerisation pose serious health risks?
While not intrinsically hazardous, it complicates disease trajectories. Characteristically:
- Psoriatic injuries metamorphose into plaques4
- Vitiligo/lichen planus lesions propagate along friction lines2, 12
- Preventative care thus becomes paramount4, 12
How does psychological stress influence pruritus?
Stress modulates itch via neuro-immunological crosstalk:
- Substance P activates neurokinin receptor 1 (NKR1 or NK1) and can modulate transient receptor potential vanilloid 1 (TRPV1) channels, both critical in the neurocutaneous pathways that transmit itch signals6, 14
- Heightened receptor activity lowers itch thresholds, meaning it makes the skin more sensitive to itch triggers15
- Clinical correlations confirm stress-driven exacerbations15
What role does aprepitant play in itch management?
The neurokinin receptor 1 (NKR1 or NK1) antagonist (originally antiemetic) disrupts pruritic signalling. Clinical studies demonstrate aprepitant’s efficacy against intractable itch across multiple dermatoses, 9 with trial data specifically supporting its efficacy against psoriatic itch.7, 9, 10 Though off-label, it represents a salvage option when conventional therapy fails.10
Final takeaway
Scratching an itch may bring momentary relief, but it often does more harm than good. For those with certain skin conditions, it can actually trigger new lesions in areas that were previously unaffected — a reaction known as the Koebner phenomenon.1, 2
Understanding how pruritus and scratching contribute to skin damage empowers individuals to take preventive steps early. Simple actions like managing dry skin, avoiding repeated trauma, and treating itching promptly can make a real difference.3,5
Mastering itch-scratch dynamics requires understanding these underlying mechanisms. As we've explored, this includes recognising how:
- Neuroimmune pathways drive the compulsion to scratch3, 6, 11
- Physical trauma triggers isomorphic responses1, 4
- Stress amplifies pruritus sensitivity15
This mechanistic literacy enables proactive avoidance of trauma and optimised self-care. If you notice that scratching leads to new patches or rashes, it's important to consult a healthcare professional. With proper guidance and evidence-based strategies, it is possible to reduce the impact of itch-related flare-ups and protect your skin long-term.12, 13
References
- Koebner phenomenon. Isomorphic response. DermNet® [Internet]. 2023 [cited 2025 Jun 27]. Available from: https://dermnetnz.org/topics/the-koebner-phenomenon.
- Sanchez DP, Sonthalia S. Koebner Phenomenon. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 [cited 2025 Jun 27]. Available from: http://www.ncbi.nlm.nih.gov/books/NBK553108/.
- Mack MR, Kim BS. The Itch–Scratch Cycle: A Neuroimmune Perspective. Trends Immunol [Internet]. 2018 [cited 2025 Jun 27]; 39(12):980–91. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8896504/.
- Sagi L, Trau H. The Koebner phenomenon. Clinics in Dermatology [Internet]. 2011 [cited 2025 Jun 27]; 29(2):231–6. Available from: https://www.sciencedirect.com/science/article/pii/S0738081X10001665.
- Kaczmarska A, Kwiatkowska D, Skrzypek KK, Kowalewski ZT, Jaworecka K, Reich A. Pathomechanism of Pruritus in Psoriasis and Atopic Dermatitis: Novel Approaches, Similarities and Differences. IJMS [Internet]. 2023 [cited 2025 Jun 27]; 24(19):14734. Available from: https://www.mdpi.com/1422-0067/24/19/14734.
- Misery L, Pierre O, Le Gall-Ianotto C, Lebonvallet N, Chernyshov PV, Le Garrec R, et al. Basic mechanisms of itch. Journal of Allergy and Clinical Immunology [Internet]. 2023 [cited 2025 Jun 27]; 152(1):11–23. Available from: https://linkinghub.elsevier.com/retrieve/pii/S0091674923006024.
- Muñoz M, Parrilla J, Rosso M, Coveñas R. Antipruritic vs. Antitumour Action of Aprepitant: A Question of Dose. Acta Derm Venerol [Internet]. 2019 [cited 2025 Jun 27]; 99(6):620–1. Available from: https://medicaljournalssweden.se/actadv/article/view/3185.
- Rinaldi G. The Itch-Scratch Cycle: A Review of the Mechanisms. Dermatol Pract Concept [Internet]. 2019 [cited 2025 Jun 27]; 9(2):90–7. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6502296/.
- He A, Alhariri JM, Sweren RJ, Kwatra MM, Kwatra SG. Aprepitant for the Treatment of Chronic Refractory Pruritus. BioMed Research International [Internet]. 2017 [cited 2025 Jun 27]; 2017:1–6. Available from: https://www.hindawi.com/journals/bmri/2017/4790810/.
- Song JS, Tawa M, Chau NG, Kupper TS, LeBoeuf NR. Aprepitant for refractory cutaneous T-cell lymphoma-associated pruritus: 4 cases and a review of the literature. BMC Cancer [Internet]. 2017 [cited 2025 Jun 27]; 17(1):200. Available from: https://doi.org/10.1186/s12885-017-3194-8.
- Ständer S, Siepmann D, Herrgott I, Sunderkötter C, Luger TA. Targeting the Neurokinin Receptor 1 with Aprepitant: A Novel Antipruritic Strategy. PLOS ONE [Internet]. 2010 [cited 2025 Jun 27]; 5(6):e10968. Available from: https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0010968.
- Koebner Phenomenon: Psoriasis & Other Causes, Signs & Treatment. Cleveland Clinic [Internet]. [cited 2025 Jun 27]. Available from: https://my.clevelandclinic.org/health/diseases/22860-koebner-phenomenon.
- Damiani G, Cazzaniga S, Conic RR, Naldi L. PRURITUS CHARACTERISTICS IN A LARGE ITALIAN COHORT OF PSORIATIC PATIENTS. J Eur Acad Dermatol Venereol [Internet]. 2019 [cited 2025 Jun 27]; 33(7):1316–24. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6857445/.
- Damiani G, Kridin K, Pacifico A, Malagoli P, Pigatto PDM, Finelli R, et al. Antihistamines-refractory chronic pruritus in psoriatic patients undergoing biologics: aprepitant vs antihistamine double dosage, a real-world data. J Dermatolog Treat. 2022; 33(3):1554–7. Available from: https://pubmed.ncbi.nlm.nih.gov/33084462/
- Andrade A, Kuah CY, Martin‐Lopez JE, Chua S, Shpadaruk V, Sanclemente G, et al. Interventions for chronic pruritus of unknown origin. Cochrane Database Syst Rev [Internet]. 2020 [cited 2025 Jun 27]; 2020(1):CD013128. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6984650/.

